Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Operating Expenses | 12,104 | 9,899 | 10,409 | 4,883 | 6,090 |
| Operating Income | -12,104 | -9,899 | -10,409 | -4,883 | -6,090 |
| Other Income | 16 | 224 | -506 | -746 | -1,370 |
| Pre-tax Income | -12,088 | -9,675 | -10,915 | -5,629 | -7,460 |
| Net Income Continuous | -12,088 | -9,675 | -10,915 | -5,629 | -8,836 |
| Net Income | $-12,088 | $-9,675 | $-10,915 | $-5,629 | $-7,460 |
| EPS Basic Total Ops | -1.30 | -0.72 | -1.06 | -0.93 | -1.20 |
| EPS Basic Continuous Ops | -0.72 | -0.64 | -0.91 | -0.60 | -1.10 |
| EPS Diluted Total Ops | -1.30 | -0.72 | -1.06 | -0.93 | -1.20 |
| EPS Diluted Continuous Ops | -0.72 | -0.64 | -0.91 | -0.60 | -1.10 |
| EBITDA(a) | $-12,092 | $-9,890 | $-10,400 | $-4,871 | $-6,060 |